Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

STAT+ Conversations: A conversation on the future of gene therapy

  • Damian Garde

By Damian Garde March 30, 2021

Reprints

Editors note: A recording of the conversation is embedded below.

Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT national biotech reporter Damian Garde will be joined by Katherine A. High, president of therapeutics at AskBio. They will be discussing the future of gene therapy, advancements in this field, and of course be taking your questions live.

advertisement

Sponsored By

Featured speakers

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Tags

More hospitals are offering child care. But they shouldn’t…
More hospitals are offering child care. But they shouldn’t have to
Lured by a bigger payday, a medical device maker…
Lured by a bigger payday, a medical device maker sold fake plastic parts. Many were implanted…
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Pharmalittle: Pfizer touts study data for hemophilia drug; former…
Pharmalittle: Pfizer touts study data for hemophilia drug; former Novartis execs cleared of bribery in Greece
European regulatory panel weighing against approval of Amylyx’s ALS…
European regulatory panel weighing against approval of Amylyx’s ALS therapy, company says
Just how vulnerable is Medicare drug negotiation to legal…
Just how vulnerable is Medicare drug negotiation to legal challenges?

Recommended Stories